Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth – Poora parichay aur strategy

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth ek equity mutual fund hai jo ki pharma sector mein invest karta hai. Iska objective hai long-term capital growth ke liye growth potential wale pharmaceutical companies mein invest karna. Ye fund un investors ke liye suitable hai jo higher risk tolerance rakhte hain aur jo healthcare sector ke high growth opportunities ka faida uthana chahte hain. Is fund ka investment style concentrated hai, jismein top pharmaceutical stocks mein investment kiya jata hai. Yadi aapko lagta hai ki pharma sector mein growth potential hai, toh ye fund aapke liye ek accha option ho sakta hai.

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth historical performance and returns

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth ki historical performance ko dekhte hain. Is fund ka 1-year return 6.4% hai, jo ki Nifty Pharma TRI benchmark se kuch upar hai. Iska 3-year return 8.06% hai, jo consistency dikhata hai. Lekin, 5-year return sirf 4.76% hai, jo ki kuch investors ke liye disappointing ho sakta hai. Volatility ki baat karein, toh is fund ka riskometer "Very High" hai, jo indicate karta hai ki is fund mein market volatility se kaafi risk hai. Iska matlab hai ki jab market down ho sakta hai, tab aapko returns mein kaafi fluctuation dekhne ko mil sakta hai. Abhi tak fund manager ki koi information nahi hai, lekin historical returns se yeh saaf hai ki pharma sector mein invest karne ka ek mixed bag experience raha hai. Iske alawa, agar hum benchmark se compare karein, toh is fund ki performance kuch sectors ke liye positive rahegi lekin kuch investors ko ye thoda riskier lag sakta hai. Isliye, ye zaruri hai ki aap apne investment horizon ko smjhe aur phir decision lein.

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth portfolio breakdown for investors

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth ki portfolio breakdown ko samjhte hain. Is fund ki top 5 holdings hain: 1. Sun Pharmaceutical Industries Ltd. (20.5%) 2. Dr. Reddy's Laboratories Ltd. (12.8%) 3. Cipla Ltd. (10.4%) 4. Divi's Laboratories Ltd. (9.8%) 5. Torrent Pharmaceuticals Ltd. (7.2%) Ye holdings isi fund ki strategy ko align karti hain, jo ki pharma sector ke established players par focus karti hai. Iske alawa, sector allocation bhi majorly pharmaceutical companies ke aas paas hai, jo ki long-term wealth creation ka ek accha tareeka hai. Yadi aap ek investor hain jo pharma sector ko samajhte hain aur ismein growth dekhtain hain, toh ye fund aapke portfolio mein diversification ka ek accha option ho sakta hai. Portfolio ki yeh strategy potential growth ko maximize karne ke liye design ki gayi hai, lekin risk ko samajhna bhi zaruri hai.

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth riskometer and downside risk

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth ka riskometer "Very High" hai. Yeh indicate karta hai ki is fund ke saath substantial risk hai, aur investors ko iski volatility ke liye tayaar rehna chahiye. High volatility ka matlab hai ki jab market mein swings hote hain, toh fund ki value bhi kaafi fluctuate kar sakti hai. Yeh fund un investors ke liye suited hai jo risk ko samajhte hain aur long-term investments mein believe rakhte hain. Agar aapka investment horizon short-term hai, toh shayad aapko yeh fund avoid karna chahiye. Sharpe ratio ki information abhi available nahi hai, lekin yeh dhyan mein rakhna chahiye ki pharma sector mein challenges aur opportunities dono hain. Isliye, aapko apne risk tolerance ke according hi investment decisions lene chahiye.

Old Bridge Mutual Fund Pharma Fund - Regular Plan - Growth pros and cons for investors

• Pros:
  • High growth potential in the pharma sector.
  • Portfolio diversification with top pharmaceutical stocks.
  • Long-term wealth creation opportunities.
  • Good historical performance relative to benchmark in certain periods.
• Cons:
  • Very high risk with significant market volatility.
  • Inconsistent long-term returns.
  • Absence of a clear fund manager can raise concerns.